MedPath

Effects of Aromatherapy Massage in Menopausal Women With Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
Registration Number
NCT05823077
Lead Sponsor
KTO Karatay University
Brief Summary

In this study, the effects of 4-week aromatherapy massage on pain, functionality, sleep quality and menopausal symptoms will be examined in individuals diagnosed with knee osteoarthritis during menopause.

Detailed Description

The aim of this study is to investigate the effect of aromatherapy massage performed with bergamot oil for 4 weeks on pain, function, sleep and menopausal symptoms in menopausal women with knee osteoarthritis. Participants will be randomly divided into 3 groups as Bergamot, placebo and control. In addition to the conventional treatment, the Bergamot group will receive 2 sessions of Bergamot oil per week for 4 weeks, and the placebo group will be massaged with 2 sessions of sweet almond oil for 4 weeks. the control group will continue conventional treatment for 4 weeks. All assessments will be performed before starting treatment and at the end of 4 weeks of treatment. Participants' pain will be evaluated by VAS, Functions by WOMAC, Sleep quality by PSQI, menopausal symptoms by Menopause Symptoms Evaluation scale. At the end of the study, the satisfaction of the participants will be evaluated with VAS.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Being between the ages of 40-65,
  • having entered the menopause,
  • being diagnosed with knee OA,
  • being at the level of OA 2-3,
  • having pain at rest in the knee VAS ≥ 4.
Exclusion Criteria
  • Any knee surgery
  • known allergies to the oils to be used

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline in pain at 4 weeksBaseline and 4 weeks

The rest, activity and night pains of the participants will be evaluated with a 10 cm Visuak Analog Scale before the treatment and at the end of the 4-week application. "0" means no pain, "10" means excruciating pain. Results will be recorded in cm.

Secondary Outcome Measures
NameTimeMethod
Change from baseline in menopause symphtoms at 4 weeksBaseline and 4 weeks

Participants' menopausal symptoms will be evaluated with the Menopause Symptoms Evaluation Scale. Higher scores indicate more menopausal symptoms. Evaluations will be made before the study and after 4 weeks of practice.

Change from baseline in function at 4 weeksBaseline and 4 weeks

Participants' functions will be evaluated with Western Ontario and McMaster Universities Osteoarthritis Index. A minimum of "0" points and a maximum of "96" points can be obtained on the scale. High scores indicate high impairment and limitation of functional status and poor quality of daily life. Evaluations will be made before the study and after 4 weeks of practice.

Patients satisfaction after the interventions4 weeks

Participants' satisfaction with the treatment over pain and function will be evaluated with Visual Analog Scale. Higher score indicate more satisfaction. Evaluation will take place after 4 weeks of study.

Change from baseline in sleep quality at 4 weeksBaseline and 4 weeks

The sleep quality of the participants will be evaluated with Pittsburgh Sleep Quality Index . The total score is between 0-21. High scores indicate poor sleep quality. Evaluations will be made before the study and after 4 weeks of practice.

Trial Locations

Locations (1)

KTO Karatay University

🇹🇷

Konya, Karatay, Turkey

KTO Karatay University
🇹🇷Konya, Karatay, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.